Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

Publisher: Karger

E-ISSN: 1421-9875|31|5-6|426-433

ISSN: 0257-2753

Source: Digestive Diseases, Vol.31, Iss.5-6, 2013-11, pp. : 426-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content